Previous studies into the mechanism of action of GSK-J4 in an acute myeloid leukemia model indicate that GSK-J4 induces cell cycle arrest and apoptosis in cancer cells via the CHOP pathway [71]. The gene discussed is DDIT3; the disease is acute myeloid leukemia.